A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Conditions:   Diabetes Mellitus, Type 1;   Impaired Hypoglycemic Awareness;   Severe Hypoglycemia
Intervention:   Biological: VX-880
Sponsor:   Vertex Pharmaceuticals Incorporated
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 30, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments